Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics
Authors:
- J. GuedjJGJ. Guedj
- A.U. NeumannANA.U. Neumann
- 1 December 2010
- journal article
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 267 (3) , 330-340
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation Israel (ISF 939/2008)
- U.S. Department of Energy (RR06555 and P20-RR18754)
This publication has 44 references indexed in Scilit:
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C VirusScience Translational Medicine, 2010
- A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant VariantsPLOS Computational Biology, 2010
- Focal Distribution of Hepatitis C Virus RNA in Infected LiversPLOS ONE, 2009
- Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha InterferonJournal of Virology, 2009
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsHepatology, 2008
- Review: Hepatitis C Protease and Polymerase Inhibitors in DevelopmentAIDS Patient Care and STDs, 2008
- Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?Journal of Antimicrobial Chemotherapy, 2008
- Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 CellsJournal of Virology, 2007
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Kinetic analysis of template-instructed and de novo RNA synthesis by Qβ replicaseJournal of Molecular Biology, 1981